02/17/2026

Health Alliance Plan

Health Alliance Plan Managed Care Committee Member

April Danish, CHONC - Newland Medical Associates

The New hap.org Is Here—Designed to Support You!

We’re excited to share that the newly redesigned hap.org is now live. This updated experience was shaped by user feedback and designed to better support you by making it easier to find the tools, resources and information you need READ MORE

Medical Record Review Projects

HAP partners with vendors to conduct medical record reviews. They contact offices directly and provide the review details, including due dates and submission requirements. READ MORE

Clinical Trials Billing Requirements Coming Soon

Effective May 1, we will implement the billing guidelines below for items and services furnished to members enrolled in approved clinical trials. For HAP Commercial plans, routine patient care costs are covered as required under the Affordable Care Act (ACA). For HAP Medicare Advantage (MA) plans, coverage of routine costs follows Medicare rules. In qualifying clinical trials, Original Medicare (FFS) processes trial-related services, and the MA plan coordinates secondary cost-sharing. READ MORE

Monthly Reminders

Here are several resources to make it easier to do business with HAP. READ MORE

• Benefit Coverage Policies
• Provider Manual
• Pharmacy Information
• And much more!    

Virtual Provider Education Meeting Coming Soon!

In case you missed the in-person provider education forums last fall, we have a virtual option coming soon:

Thursday, March 5, 2026
Noon – 1:00 pm

REGISTER HERE

Changes for Specific J-Codes and Q-Codes Coming Soon

Prior Authorization for J9172 and J9174

Effective April 1, 2026, the codes below will require prior authorization for members in HAP Medicare Advantage plans, HAP Commercial plans and HAP Qualified Health Plans (off-exchange).

• J9172: Injection, docetaxel (ingenus) not therapeutically equivalent to J9171, 1 mg
• J9174: Injection, docetaxel (beizray), 1 mg

NOTE: J9171: Injection, Docetaxel, 1 MG is covered. No prior authorization is required